MoneyWorks4Me

Unichem Laboratories - Quaterly Results

12 Aug 2026 Evaluate
A slight decline in the revenue of Rs. 3662.70 millions was seen for the June 2026 quarter as against Rs. 3842.50 millions during year-ago period.The Total Profit for the quarter ended June 2026 of Rs. 55.30 millions grew from Rs.-18.50 millionsOperating profit for the quarter ended June 2026 rose to 373.60 millions as compared to 299.90 millions of corresponding quarter ended June 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 3662.70 3842.50 -4.68 3662.70 3842.50 -4.68 14122.90 17357.00 -18.63
Other Income 167.20 42.50 293.41 167.20 42.50 293.41 629.00 408.30 54.05
PBIDT 373.60 299.90 24.57 373.60 299.90 24.57 1132.60 2947.10 -61.57
Interest 12.90 19.30 -33.16 12.90 19.30 -33.16 118.00 76.20 54.86
PBDT 360.70 280.60 28.55 360.70 280.60 28.55 3284.40 2910.90 12.83
Depreciation 286.90 299.30 -4.14 286.90 299.30 -4.14 1190.30 1084.10 9.80
PBT 73.80 -18.70 -494.65 73.80 -18.70 -494.65 2094.10 1826.80 14.63
TAX 18.50 -0.20 -9350.00 18.50 -0.20 -9350.00 504.70 197.20 155.93
Deferred Tax 18.50 -4.60 -502.17 18.50 -4.60 -502.17 500.30 197.20 153.70
PAT 55.30 -18.50 -398.92 55.30 -18.50 -398.92 1589.40 1629.60 -2.47
Equity 140.80 140.80 0.00 140.80 140.80 0.00 140.80 140.80 0.00
PBIDTM(%) 10.20 7.80 30.69 10.20 7.80 30.69 8.02 16.98 -52.77

Unichem Laboratories Share Price

525.80 7.70 (1.49%)
21-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1900.90
Dr. Reddys Labs. 1175.00
Cipla 1426.20
Lupin 2193.00
Zydus Lifesciences 1120.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: